首页> 外国专利> Application of Rimycin in Anti-tuberculosis Mycobacterium Infection

Application of Rimycin in Anti-tuberculosis Mycobacterium Infection

机译:利霉素在抗结核分枝杆菌感染中的应用

摘要

calimycin applications in resistance to mycobacterium tuberculosis infection. The applications comprise the following main steps: using the frequently used clinical antituberculosis drugs, isoniazid and rifamycin, as a contrast, detecting the activity of calimycin on the resistance of mycobacterium tuberculosis using an absolute concentration method. the result indicates that the activity of calimicin on clinically separated mycobacterium tuberculosis comprising drug-resistant bacteria is remarkably superior to that of the frequently used clinical contrast drugs, isoniazid and rifamycin, and it is expected that applications of calimycin in the preparation of drugs for the treatment of diseases caused by mycobacterium tuberculosis are developed.
机译:卡利霉素在抗结核分枝杆菌感染中的应用。应用程序包括以下主要步骤:使用常用的临床抗结核药异烟肼和利福霉素作为对照,使用绝对浓缩法检测卡利霉素对结核分枝杆菌耐药性的活性。结果表明,卡利霉素对包含耐药菌的临床分离的结核分枝杆菌的活性明显优于常用的临床对比药物异烟肼和利福霉素,并且可以预期卡利霉素在制备抗结核药中的应用已经开发了治疗由结核分枝杆菌引起的疾病的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号